PET/CT in lung cancer: Influence of contrast medium on quantitative and clinical assessment.

Objectives: To evaluate the influence of intravenous contrast medium and different contrast medium phases on attenuation correction, PET image quality and clinical staging in combined PET/CT in patients with a suspicion of lung cancer.Methods: Sixty patients with a suspicion of lung cancer were pros...

Descripción completa

Detalles Bibliográficos
Publicado en:European Radiology Vol. 22; no. 11; pp. 2458 - 2465
Autores principales: Behrendt FF, Temur Y, Verburg FA, Palmowski M, Krohn T, Pietsch H, Kuhl CK, Mottaghy FM, Behrendt, Florian F, Temur, Yavuz, Verburg, Frederik A, Palmowski, Moritz, Krohn, Thomas, Pietsch, Hubertus, Kuhl, Christiane K, Mottaghy, Felix M
Formato: research Journal Article
Publicado: Springer Nature Nov2012
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104375027&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104375027
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09387994
        NPH
      jtl: European Radiology
      issn: 09387994
      maglogo: N
    pubinfo:
      dt: Nov2012
      vid: 22
      iid: 11
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        104375027
        82504636
        NLM22661058
        2011718117
        10.1007/s00330-012-2515-1
        NLM22661058
        104375027
      ppf: 2458
      ppct: 7
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: PET/CT in lung cancer: Influence of contrast medium on quantitative and clinical assessment.
      aug:
        au:
          Behrendt FF
          Temur Y
          Verburg FA
          Palmowski M
          Krohn T
          Pietsch H
          Kuhl CK
          Mottaghy FM
          Behrendt, Florian F
          Temur, Yavuz
          Verburg, Frederik A
          Palmowski, Moritz
          Krohn, Thomas
          Pietsch, Hubertus
          Kuhl, Christiane K
          Mottaghy, Felix M
        affil: Department of Nuclear Medicine, University Hospital, RWTH-Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany
      sug:
        subj:
          Contrast Media Pharmacodynamics
          Lung Neoplasms Diagnosis
          Lung Neoplasms Radiography
          Tomography, Emission-Computed Methods
          Tomography, X-Ray Computed Methods
          Adult
          Aged
          Aged, 80 and Over
          Female
          Human
          Image Processing, Computer Assisted
          Male
          Oncology Methods
          Middle Age
          Radiographic Image Interpretation, Computer-Assisted
          Reproducibility of Results
          Adult: 19-44 years
          Aged: 65+ years
          Aged, 80 & over
          Middle Aged: 45-64 years
          Female
          Male
      ab: Objectives: To evaluate the influence of intravenous contrast medium and different contrast medium phases on attenuation correction, PET image quality and clinical staging in combined PET/CT in patients with a suspicion of lung cancer.Methods: Sixty patients with a suspicion of lung cancer were prospectively enrolled for combined (18)F-FDG-PET/CT examination. PET images were reconstructed with non-enhanced and arterial and venous phase contrast CT. Maximum and mean standardised uptake values (SUVmax and SUVmean) and contrast enhancement (HU) were determined in the subclavian vein, ascending aorta, abdominal aorta, inferior vena cava, portal vein, liver and kidney and lung tumour. PET data were evaluated visually for clinical staging and image quality.Results: SUVmax was significantly increased between contrast and non-contrast PET/CT at all anatomic sites (all P < 0.001). SUVmax was significantly increased for arterial PET/CT compared to venous PET/CT in the arteries (all P < 0.001). Venous PET/CT resulted in significantly higher SUVmax values compared to arterial PET/CT in the parenchymatous organs (all P < 0.05). Visual clinical evaluation of malignant lesions showed no differences between contrast and non-contrast PET/CT (P = 1.0).Conclusions: Contrast enhanced CT is suitable for attenuation correction in combined PET/CT in lung cancer; it affects neither the clinical assessment nor image quality of the PET images.Key Points: • Positron emission tomography combined with computed tomography is now a mainstream investigation • There has been debate about whether CT contrast agents affect PET results • Contrast-enhanced CT is satisfactory for attenuation correction in lung cancer PET/CT • Multiphase CT does not affect PET; additional unenhanced CT is unnecessary • For quantitative follow-up PET analysis, an identical PET/CT protocol is required.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N